femoston conti 15 tablet
abbott laboratories (singapore ) private limited - dydrogesterone micronized; estradiol hemihydrate 1.03 mg eqv estradiol (micronised) - tablet, film coated - 5 mg - dydrogesterone micronized 5 mg; estradiol hemihydrate 1.03 mg eqv estradiol (micronised) 1 mg
femoston-conti tablet blister pack
viatris pty ltd - estradiol, quantity: 1 mg (equivalent: estradiol hemihydrate, qty 1.03 mg); dydrogesterone, quantity: 5 mg - tablet, film coated - excipient ingredients: lactose monohydrate; maize starch; hypromellose; magnesium stearate; colloidal anhydrous silica; titanium dioxide; iron oxide yellow; iron oxide red; macrogol 400 - hormone replacement therapy (hrt) in oestrogen deficiency associated with natural or artificial menopause in women with an intact uteri. prevention of postmenopausal bone mineral density loss in women. for initiation and continuation of treatment of postmenopausal symptoms, the lowest possible effective dose for the shortest duration should be used with the goal being short term use.
femoston conti tablet, film coated 1mg/5mg
mylan products limited - dydrogesterone; estradiol - film-coated tablet - dydrogesterone 5 mg; estradiol 1 mg - sex hormones and modulators of the genital system
femoston 2 mg, 10 m milligram film coated tablet
bgp products ltd - estradiol hemihydrate, dydrogesterone - film coated tablet - 2 mg, 10 m milligram - progestogens and estrogens, sequential preparations - sequential hormone replacement therapy - hormone replacement therapy (hrt) for estrogen deficiency symptoms in postmenopausal women at least 6 months since the last menses. prevention of osteoporosis in postmenopausal women at high risk of future fractures who are intolerant of, or contraindicated for, other medicinal products approved for the prevention of osteoporosis.
femoston 1 mg, 10 m milligram film coated tablet
bgp products ltd - estradiol hemihydrate, dydrogesterone - film coated tablet - 1 mg, 10 m milligram - progestogens and estrogens, sequential preparations
femoston conti 1/5 mg tablets
abbott laboratories s.a. (pty) ltd 219 golf club terrace constantia kloof , - oestradiol/ dydrogesterone - tablet - each film-coated tablet contains oestradiol - hormonal contraceptives: progestogens for
femurest-conti 1/5 milligram film coated tablet
abbott healthcare products ltd - estradiol hemihydrate dydrogesterone - film coated tablet - 1/5 milligram
femoston conti film-coated tablets
abbott healthcare products limited - dydrogesterone 5 mg, estradiol 1 mg - film-coated tablet
femoston conti 0.5 mg2.5 mg
abbott medical laboratories ltd, israel - dydrogesterone; estradiol as hemihydrate - film coated tablets - dydrogesterone 2.5 mg; estradiol as hemihydrate 0.5 mg - dydrogesterone and estrogen - hormone replacement therapy (hrt) for estrogen deficiency symptoms in postmenopausal women at least 12 months since last menses.femoston is indicated for women with an intact uterus
femoston conti 1 mg5 mg
abbott medical laboratories ltd, israel - dydrogesterone; estradiol as hemihydrate - film coated tablets - dydrogesterone 5 mg; estradiol as hemihydrate 1 mg - dydrogesterone and estrogen - hormone replacement therapy (hrt) for estrogen deficiency symptoms in postmenopausal women at least 12 months since last menses.prevention of osteoporosis in postmenopausal women at high risk of future fractures. femoston contini 1/5 should only be used in patients who are intolerant of other products, approved for the prevention of osteoporosis or for whom these products are contra-indicated.femoston is indicated for women with an intact uterus